Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Nat Genet. 2010 Apr;42(4):313-21. doi: 10.1038/ng.544. Epub 2010 Mar 7.
Autosomal dominant spinocerebellar ataxias (SCAs) are genetically heterogeneous neurological disorders characterized by cerebellar dysfunction mostly due to Purkinje cell degeneration. Here we show that AFG3L2 mutations cause SCA type 28. Along with paraplegin, which causes recessive spastic paraplegia, AFG3L2 is a component of the conserved m-AAA metalloprotease complex involved in the maintenance of the mitochondrial proteome. We identified heterozygous missense mutations in five unrelated SCA families and found that AFG3L2 is highly and selectively expressed in human cerebellar Purkinje cells. m-AAA-deficient yeast cells expressing human mutated AFG3L2 homocomplex show respiratory deficiency, proteolytic impairment and deficiency of respiratory chain complex IV. Structure homology modeling indicates that the mutations may affect AFG3L2 substrate handling. This work identifies AFG3L2 as a novel cause of dominant neurodegenerative disease and indicates a previously unknown role for this component of the mitochondrial protein quality control machinery in protecting the human cerebellum against neurodegeneration.
常染色体显性遗传性小脑共济失调(SCAs)是一组遗传异质性的神经退行性疾病,其主要特征为小脑功能障碍,大多由于浦肯野细胞退化所致。本研究显示 AFG3L2 突变可导致 SCA 28 型。与导致常染色体隐性痉挛性截瘫的 paraplegin 一样,AFG3L2 是保守的 m-AAA 金属蛋白酶复合物的组成部分,该复合物参与维持线粒体蛋白质组。我们在五个无关联的 SCA 家族中鉴定出杂合错义突变,发现 AFG3L2 在人类小脑浦肯野细胞中高度且选择性表达。表达人突变 AFG3L2 同源复合物的 m-AAA 缺陷酵母细胞表现出呼吸缺陷、蛋白水解损伤以及呼吸链复合物 IV 缺乏。结构同源建模表明,这些突变可能影响 AFG3L2 的底物处理。本研究鉴定出 AFG3L2 是一种新的显性神经退行性疾病的致病基因,并表明线粒体蛋白质量控制机制的这一组成部分在保护人类小脑免受神经退行性变方面具有未知的作用。